Sep 05, 2023
SALT LAKE CITY , Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: Citi's 18th Annual BioPharma Conference  – September 6-7,
Aug 01, 2023
SALT LAKE CITY , Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conference: KeyBanc Technology Leadership Forum  – August 6-8, 2023
Jun 01, 2023
SALT LAKE CITY , June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: Goldman Sachs 44th Annual Global Healthcare Conference – June
Displaying 1 - 10 of 80